Early CD4+ Immune Reconstitution Predicts Probability of Relapse in Pediatric AML after Unrelated Cord Blood Transplantation: Importance of Preventing in Vivo T-Cell Depletion Using Thymoglobulin®  Rick Admiraal, MD, Robert Chiesa, MD, PhD, Marc Bierings, MD, PhD, A. Birgitta Versluijs, MD, Prashant Hiwarkar, MD, Juliana Silva, MD, Paul Veys, MD, Jaap Boelens, MD, PhD  Biology of Blood and Marrow Transplantation  Volume 21, Issue 2, (February 2015) DOI: 10.1016/j.bbmt.2014.11.315 Copyright © 2015 Terms and Conditions

Figure 1 Cumulative incidence of relapse according to CD4+ immune reconstitution in myeloid leukemia Biology of Blood and Marrow Transplantation 2015 21, DOI: (10.1016/j.bbmt.2014.11.315) Copyright © 2015 Terms and Conditions

Figure 2 Non-relapse mortality according to CD4+ immune reconstitution in all patients Biology of Blood and Marrow Transplantation 2015 21, DOI: (10.1016/j.bbmt.2014.11.315) Copyright © 2015 Terms and Conditions